Moderna | MRNA - Interest Expense On Debt


Moderna reported $11.49B in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Acadia Pharmaceuticals USD 0 4.12M Sep/2024
Agios Pharmaceuticals USD 1.18B 4.3B Mar/2026
Alnylam Pharmaceuticals USD 69.29M 60.05M Mar/2026
Amgen USD 657M 4M Mar/2026
Arrowhead Research USD 22.5M 811K Dec/2025
Biogen USD 72.6M 12.6M Jun/2025
BioMarin Pharmaceutical USD 14.96M 12.18M Mar/2026
Celltrion KRW 19B 1.96B Jun/2025
Cspc Pharmaceutical CNY 6.76M 3.43M Dec/2025
Deva Holding AS TRY 272.53M 69.04M Sep/2023
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Divis Laboratories Ltd INR 60M 0 Mar/2026
Esperion Therapeutics USD 22.64M 585K Dec/2025
Gilead Sciences USD 240M 15M Mar/2026
GlaxoSmithKline GBP 167M 21M Mar/2026
Incyte USD 569K 13K Mar/2026
Ionis Pharmaceuticals USD 17M 1000K Mar/2026
Kangmei Pharma CNY 1.82M 150K Sep/2025
Knight Therapeutics CAD 3.92M 1.56M Dec/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Moderna USD 11.49B 36B Mar/2026
Organigram Holdings CAD 179K 127K Mar/2025
Ovoca Bio EUR 7K 6K Jun/2022
Pharma Mar EUR 117K 1.24M Sep/2025
Puma Biotechnology USD 3.37M 11K Jun/2024
Qiagen NV USD 10.14M 1.92M Dec/2025
Regeneron Pharmaceuticals USD 12.9M 700K Mar/2026
Sangamo BioSciences 97.56M 11.39M Jun/2025
Sarepta Therapeutics USD 20.84M 13.28M Dec/2025
Sartorius EUR 49.5M 8.1M Sep/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Tilray USD 6.7M 2.73M Jun/2025
Ultragenyx Pharmaceutical USD 21M 2M Mar/2026
United Therapeutics USD 3.1M 100K Dec/2025
Vertex Pharmaceuticals USD 3.3M 0 Dec/2025
Zealand Pharma A/S 7.07M 74K Dec/2025
Zz Pientze Pharmaceu CNY 46.05M 36.5M Jun/2025